| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | serdemetan | FIMM | pan-cancer | AAC | 0.31 | 0.04 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.096 | 0.04 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.04 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.04 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.04 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | 0.31 | 0.04 |